BB&T Corp lessened its holdings in AstraZeneca plc (NYSE:AZN) by 14.1% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 70,896 shares of the company’s stock after selling 11,595 shares during the period. BB&T Corp’s holdings in AstraZeneca were worth $3,160,000 as of its most recent SEC […]
